Refraction and eye anterior segment parameters in schizophrenic patients / Refração e parâmetros do segmento anterior ocular em pacientes com esquizofrenia

ABSTRACT Purpose: To evaluate the difference in terms of refractive errors and anterior segment parameters between schizophrenic patients and healthy volunteers. Methods: This study compared 70 patients (48 men) who were diagnosed with schizophrenia with a control group of 60 (35 men) who were similar in terms of age, gender, education, and socioeconomic level. Anterior segment examination was performed using a Scheimflug system. Axial length and lens thickness (LT) were measured using optic biometry. The following tests were administered to the psychiatric patient group: Brief Psychiatric Rating Scale (BPRS), Scale for the Assessment of Negative Symptoms (SANS), and Scale for the Assessment of Positive Symptoms (SAPS). Results: Mild myopia was detected in both the schizophrenic and control groups, with no statistically significant difference (p>0.005). Corneal volume (CV), anterior chamber volume (ACV), anterior chamber depth (ACD), and central corneal thickness (CCT) values were lower in the schizophrenic group, and there was a statistically significant between-group difference (p=0.026, p=0.014, p=0.048, and p=0.005, respectively). LT was greater in schizophrenics, and the difference was found to be statistically significant (p=0.006). A statistically significant negative correlation was found between SAPS and cylinder values (p=0.008). The axial eye length, cylinder value, pupil diameter, mean keratometric value, and anterior chamber angle revealed no statistically significant difference between the groups (p>0.05). Conclusion: No statistically significant difference was detected in terms of refraction disorders between schizophrenics and the healthy control group, while some differences in anterior chamber parameters were present. These results demonstrate that schizophrenics may exhibit clinical and structural differences in the eye. .

RESUMO Objetivo: Avaliar se existem diferenças em relação aos erros refracionais e parâmetros do segmento anterior entre pacientes com esquizofrenia e voluntários saudáveis. Métodos: Este estudo comparou 70 pacientes diagnosticados com esquizofrenia (48 homens) com um grupo controle de 60 pacientes, semelhantes em relação à idade, sexo, escolaridade e nível socioeconômico (35 homens). O exame do segmento anterior foi realizado com o sistema Scheimflug; os comprimentos axiais do olho e a espessura do cristalino foram avaliadas por meio de biometria óptica. Os seguintes testes foram aplicados ao grupo de pacientes psiquiátricos: Brief Psychiatric Rating Scale (BPRS), Scale for the Assessment of Negative Symptoms (SANS), e Scale for the Assessment of Positive Symptoms (SAPS). Resultados: Miopia leve foi detectada em ambos os grupos de esquizofrenia e de controle, sem diferença estatisticamente significativa (p>0,005). Volume de córnea (CV), volume da câmara anterior (ACV), profundidade da câmara anterior (ACD) e paquimetria central da córnea (CCT) apresentaram valores menores no grupo de esquizofrênicos e houve diferença estatisticamente significativa entre os dois grupos (p=0,026, p=0,014, p=0,048 e p=0,005, respectivamente). A espessura do cristalino (LT) foi maior em esquizofrênicos e a diferença foi estatisticamente significativa (p=0,006). Foi encontrada uma correlação negativa estatisticamente significativa entre SAPS e os valores cilíndricos (p=0,008). O comprimento axial do olho, o valor do cilindro, o diâmetro pupilar, a ceratometria média e o ângulo da câmara anterior não revelaram nenhuma diferença estatística entre os grupos (p>0,05). Conclusões: Não foi detectada diferença estatisticamente significativa em relação aos transtornos de refração entre os esquizofrênicos e o grupo controle, enquanto algumas diferenças nos parâmetros de câmara anterior estavam presentes. Estes resultados demonstram que esquizofrénicos podem ...

Role of psychiatric disorders and irritable bowel syndrome in asthma patients

OBJECTIVES: The goals of the study were the following: 1) to determine the frequency of psychiatric disorders and irritable bowel syndrome in patients with asthma and 2) to compare the frequency of these disorders in patients with asthma to their frequency in healthy controls. INTRODUCTION: Patients with asthma have a higher frequency of irritable bowel syndrome and psychiatric disorders. METHODS: We evaluated 101 patients with bronchial asthma and 67 healthy subjects. All subjects completed the brief version of the Bowel Symptoms Questionnaire and a structured clinical interview for DSM-IV axis disorders (SCID-I/CV). RESULTS: There were 37 cases of irritable bowel syndrome in the group of 101 stable asthma patients (36.6 percent) and 12 cases in the group of 67 healthy subjects (17.9 percent) (p = 0.009). Irritable bowel syndrome comorbidity was not related to the severity of asthma (p = 0.15). Regardless of the presence of irritable bowel syndrome, psychiatric disorders in asthma patients (52/97; 53.6 percent) were more common than in the control group (22/63, 34.9 percent) (p = 0.02). Although psychiatric disorders were more common in asthma patients with irritable bowel syndrome (21/35, 60 percent) than in those without irritable bowel syndrome (31/62, 50 percent), the difference was not significant (p = 0.34). In asthma patients with irritable bowel syndrome and psychiatric disorders, the percentage of forced expiratory volume in 1 s (FEV1) was lower than it was in those with no comorbidities (p = 0.02). CONCLUSIONS: Both irritable bowel syndrome and psychiatric disorders were more common in asthma patients than in healthy controls. Psychiatric disorders were more common in asthma patients with irritable bowel syndrome than in those without irritable bowel syndrome, although the differences failed to reach statistical significance. In asthma patients with IBS and psychiatric disorders, FEV1s were significantly lower than in other asthma patients. It is important for clinicians to accurately recognize that these comorbid conditions are associated with additive functional impairment.